Tüdőrák: vizsgálatok itt: Egyesült Államok
901 trials · From ClinicalTrials.gov, checked 2026. november 18.. Ask the study team whether a trial fits you.
- 2. fázisTaking people18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection
- Where
- Bethesda
- Életkor
- 18 év to 120 év
- People
- 320
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT06503146 - 3. fázisTaking peopleA Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)
- Where
- Alexandria, Anaheim, Athens, Atlanta, Baltimore, Baton Rouge, Bay Pines, Bend, Bethesda, Beverly Hills, Boise, Bridgeton, Buffalo, Camden, Chattanooga, Chicago, Cincinnati, Columbia, Covington, Decatur, Detroit, Duluth, East Syracuse, Fairfax, Fort Lauderdale, Fort Wayne, Fort Worth, Fredericksburg, Gainesville, Grand Forks, Grand Rapids, Hershey, Hinsdale, Houston, Jacksonville, Kansas City, Kingwood, Lexington, Lincoln, Loma Linda, Los Alamitos, Louisville, Lubbock, Medford, Nashville, Newark, Olympia, Quincy, Redlands, Rochester, Rockford, Round Rock, Saginaw, Salem, San Francisco, Savannah, Scarborough, Seattle, Shreveport, Silverdale, Sioux Falls, Spokane, Springdale, Tacoma, Tucson, Walnut Creek, Waterloo, Wenatchee, Westbury, West Haven, Wilson, York
- Életkor
- 18 év and over
- People
- 1160 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06692738 · EU 2024-514281-39-00 - 1. fázisTaking peopleA Phase 1 Study of LNCB74 in Advanced Solid Tumors
- Where
- Boston, Buffalo, Cleveland, Edgewood, Falls Church, Hackensack, Houston, Nashville, Newport Beach, New York, Philadelphia, Pittsburgh, Salt Lake City, San Antonio, St Louis
- Életkor
- 18 év and over
- People
- 145
- Run by
- LigaChem Biosciences, Inc.
See details and how to joinNCT06774963 - 2. fázisTaking peopleCemiplimab and Fianlimab Before Surgery for the Treatment of Stage IB-IIIB Non-Small Cell Lung Cancer
- Where
- Jacksonville, Rochester
- Életkor
- 18 év and over
- People
- 60
- Run by
- Mayo Clinic
See details and how to joinNCT06918132 - 2. fázisTaking peopleDB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors
- Where
- Anderson, Atlanta, Bethesda, Charleston, Florida City, Houston, Lincoln, Los Angeles, New York, Portland, Puyallup, Spokane, Virginia Beach, Wheat Ridge
- Életkor
- 18 év and over
- People
- 750 worldwide
- Run by
- DualityBio Inc.
See details and how to joinNCT06953089 · EU 2025-523895-22-00 - 1. fázisTaking peopleA Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
- Where
- Atlanta, Buffalo, Cleveland, Fairfax, Grand Rapids, Hackensack, Irving, Jefferson, New York, Santa Monica, St Louis
- Életkor
- 18 év and over
- People
- 404 worldwide
- Run by
- Astellas Pharma Inc
See details and how to joinNCT07094204 · EU 2025-522082-29-00 - No phaseTaking peopleA Restorative Justice-Based Lung Cancer Screening Decision-Making Support Intervention Tailored for Black Individuals to Increase Lung Cancer Screening Among Black Community Members, RESTORE Trial
- Where
- Seattle
- Életkor
- 50 év to 77 év
- People
- 45
- Run by
- Fred Hutchinson Cancer Center
See details and how to joinNCT07490860 - 1. fázisTaking peopleAutologous B7-H3 Chimeric Antigen Receptor T Cells in Previously Treated Extensive-Stage Small Cell Lung Cancer With Recurrent or Refractory Disease
- Where
- Bethesda
- Életkor
- 18 év to 120 év
- People
- 40
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT07509034 - No phaseCsak meghívásosPatient Reported Outcomes Following Percutaneous Lung Ablation
- Where
- Rochester
- Életkor
- 18 év and over
- People
- 50
- Run by
- Mayo Clinic
See details and how to joinNCT07720102 - No phaseTaking peopleAvera Cancer Sequencing and Analytics Protocol (ASAP)
- Where
- Aberdeen, Marshall, Mitchell, Pierre, Sioux Falls, Yankton
- Életkor
- 18 év and over
- People
- 25 000
- Run by
- Avera McKennan Hospital & University Health Center
See details and how to joinNCT05142033 - 1. fázisTaking peopleKK-LC-1 TCR-T Cell Therapy for Gastric, Breast, Cervical, and Lung Cancer
- Where
- New Brunswick
- Életkor
- 18 év and over
- People
- 30
- Run by
- Christian Hinrichs
See details and how to joinNCT05483491 - 2. fázisTaking peopleBiologically Guided Radiation Therapy (BgRT) and Stereotactic Body Radiation Therapy (SBRT) to Tyrosine Kinase Inhibitor in Oligoprogressive Oncogenic Positive Non-Small Cell Lung Carcinoma
- Where
- Duarte, New Haven
- Életkor
- 18 év and over
- People
- 32
- Run by
- City of Hope Medical Center
See details and how to joinNCT06014827 - 1. fázisTaking peopleA Study of MGC026 in Participants With Advanced Solid Tumors
- Where
- Grand Rapids, Houston, Lake Success, Los Angeles, Portland, West Valley City
- Életkor
- 18 év and over
- People
- 394 worldwide
- Run by
- MacroGenics
See details and how to joinNCT06242470 - 3. fázisTaking peoplePhase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations
- Where
- Anaheim, Anchorage, Annapolis, Appleton, Atlanta, Beverly Hills, Boston, Bozeman, Chattanooga, Cincinnati, Clermont, Columbus, Dearborn, Farmington Hills, Fort Belvoir, Fort Worth, Fountain Valley, Gainesville, Grand Island, Grand Rapids, Greenville, Hattiesburg, Hinsdale, Houston, Kansas City, Kingwood, Knoxville, Las Vegas, Leesburg, Little Rock, Maumee, Miami Beach, Midlothian, Newport Beach, Noblesville, Odessa, Omaha, Orange City, Orlando, Paducah, Portland, Reno, Richmond, Salisbury, Sioux Falls, Springdale, Stony Brook, Tacoma, Toledo, Traverse City, Tucson, Vancouver, Voorhees Township, Wenatchee, West Palm Beach
- Életkor
- 18 év and over
- People
- 675 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06357533 · EU 2023-505077-32-00 - 3. fázisTaking peopleA Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Non-Squamous NSCLC
- Where
- Alexandria, Anaheim, Atlanta, Baltimore, Baton Rouge, Bay Pines, Bethesda, Beverly Hills, Boise, Bridgeton, Buffalo, Camden, Canton, Chandler, Chattanooga, Chicago, Columbia, Decatur, Duluth, Fairfax, Fort Lauderdale, Fort Worth, Gainesville, Grand Rapids, Hinsdale, Houston, Irving, Jacksonville, Kingwood, La Crosse, Lexington, Lincoln, Loma Linda, Lone Tree, Louisville, Lubbock, Medford, Miami, Mobile, Nashville, Newark, Norfolk, Ocala, Palestine, Phoenix, Pierre, Pittsburgh, Portland, Providence, Quincy, Redlands, Roanoke, Rochester, Rockford, Round Rock, Saint Paul, Salem, San Diego, San Francisco, Santa Rosa, Seattle, Shreveport, Silverdale, Sioux Falls, South Portland, Spokane, Stamford, St. Petersburg, Tacoma, Walnut Creek, Waterloo, Wenatchee, Westbury, West Haven, York
- Életkor
- 18 év and over
- People
- 1160 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06627647 · EU 2024-515008-38-00 - 2. fázisTaking peopleA Study of Stereotactic Radiosurgery (SRS) and Standard Treatment in People With Lung Cancer That Has Spread to the Brain
- Where
- Basking Ridge, Commack, Harrison, Miami, Middletown, Montvale, New York, Rockville Centre
- Életkor
- 18 év and over
- People
- 56
- Run by
- Memorial Sloan Kettering Cancer Center
See details and how to joinNCT06741085 - 1/2. fázisTaking peopleA Study to Investigate ALE.P02 as a Monotherapy or in Combination With Pembrolizumab in Adult Patients With Selected CLDN1+ Solid Tumors
- Where
- Chicago, Fairfax, Fullerton, Hackensack, Los Angeles, Louisville, New Haven, Scottsdale
- Életkor
- 18 év and over
- People
- 235 worldwide
- Run by
- Alentis Therapeutics AG
See details and how to joinNCT06747585 · EU 2024-515459-39-00 - 1/2. fázisTaking peopleA Platform Study in Non-Small Cell Lung Cancer (NSCLC)
- Where
- Baltimore, Cleveland, Detroit, Jacksonville, Phoenix, Providence, Rochester, Santa Rosa, Tyler
- Életkor
- 18 év and over
- People
- 152 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06996782 · EU 2024-519786-22-01 - 1/2. fázisTaking peopleA Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
- Where
- Austin, Boston, Cleveland, Duarte, Fairfax, Houston, Huntersville, Irvine, Milwaukee, Nashville, Omaha, Orlando, Rochester, San Antonio, St Louis, West Valley City, Zion
- Életkor
- 18 év and over
- People
- 248 worldwide
- Run by
- Terremoto Biosciences Inc.
See details and how to joinNCT07109726 - 4. fázisTaking peopleAn Open-label, Single-arm Study of Prophylaxis for Datopotamab Deruxtecan (Dato-DXd) -Related Stomatitis in Eligible Patients With Metastatic or Inoperable Locally Recurrent Breast Cancer or Locally Advanced or Metastatic Epidermal Growth Factor Receptor-Mutated Non-small Cell Lung Cancer.
- Where
- Athens, Boise, Charleston, Cleveland, Coral Springs, Detroit, Duarte, East Syracuse, Elizabethtown, Fairfax, Fort Wayne, Frederick, Glendale, Glenn Dale, Grayling, Greensboro, Hot Springs, Kansas City, Knoxville, Lakewood, Lebanon, Lexington, Little Rock, Long Beach, Louisville, Minneapolis, Morgantown, New Orleans, Park Ridge, Plantation, Reno, Torrance, Tucson, Washington D.C., Waukesha, Westbury, West Columbia, White Plains, Wilson, Wynnewood
- Életkor
- 18 év and over
- People
- 100
- Run by
- AstraZeneca
See details and how to joinNCT07357597 - No phaseTaking peopleA Study of a Side Effects and Resource Navigation Program for People With Cancer
- Where
- Basking Ridge, Commack, Harrison, Middletown, Montvale, New York, Rockville Centre
- Életkor
- 18 év and over
- People
- 200
- Run by
- Memorial Sloan Kettering Cancer Center
See details and how to joinNCT07646847 - 1. fázisNot yet taking people in Egyesült ÁllamokA Phase 1a/1b Of Zanidatamab In Combination With Zongertinib In HER2-Mutated Non-Small Cell Lung Cancer (NSCLC)
- Where
- Houston
- Életkor
- 18 év and over
- People
- 24
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT07899801 - 1/2. fázisTaking peoplePET/CT Imaging of Small Cell Lung Cancer Using 89Zr-DFO-SC16.56
- Where
- New York
- Életkor
- 18 év and over
- People
- 105
- Run by
- Memorial Sloan Kettering Cancer Center
See details and how to joinNCT04199741 - 1/2. fázisTaking peopleStudy to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor in Adult Participants With Advanced or Metastatic Non-Squamous NSCLC With No Prior Treatment for Advanced Disease, and No Actionable Genomic Alterations
- Where
- Aurora, Boston, Cleveland, Columbus, Detroit, Duluth, East Brunswick, Easton, Fort Wayne, Fullerton, Hinsdale, Houston, Indianapolis, Jacksonville, Leesburg, Lone Tree, Lubbock, Olympia, Orange City, Overland Park, Oxnard, Phoenix, Rochester, Salt Lake City, Santa Monica, Shirley, Tacoma
- Életkor
- 18 év and over
- People
- 252 worldwide
- Run by
- AbbVie
See details and how to joinNCT06772623 · EU 2024-514465-18-00 - 2. fázisTaking peopleA Study to Evaluate the Optimal Dose, Adverse Events and Change in Disease Activity of Intravenous ABBV-706 in Combination With Atezolizumab Versus Standard of Care as First-Line Treatment in Adult Participants With Previously Untreated Extensive Stage Small Cell Lung Cancer
- Where
- Boston, Cleveland, Columbia, Detroit, Fairfax, Fort Wayne, Gainesville, Houston, Lexington, New Haven, Ocala, Tampa
- Életkor
- 18 év and over
- People
- 180 worldwide
- Run by
- AbbVie
See details and how to joinNCT07155174 · EU 2024-517490-24-00